IONS logo

Ionis Pharmaceuticals, Inc. (IONS) Cash From Operations

Annual CFO:

-$500.95M-$193.43M(-62.90%)
December 31, 2024

Summary

  • As of today, IONS annual cash from operations is -$500.95 million, with the most recent change of -$193.43 million (-62.90%) on December 31, 2024.
  • During the last 3 years, IONS annual cash from operations has fallen by -$531.75 million (-1726.50%).
  • IONS annual cash from operations is now -183.09% below its all-time high of $602.89 million, reached on December 31, 2018.

Performance

IONS Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONScash flow metrics

Quarterly CFO:

-$131.44M-$282.77M(-186.85%)
September 1, 2025

Summary

  • As of today, IONS quarterly cash from operations is -$131.44 million, with the most recent change of -$282.77 million (-186.85%) on September 1, 2025.
  • Over the past year, IONS quarterly cash from operations has dropped by -$16.45 million (-14.30%).
  • IONS quarterly cash from operations is now -126.27% below its all-time high of $500.24 million, reached on June 30, 2018.

Performance

IONS Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONScash flow metrics

TTM CFO:

-$247.01M-$16.45M(-7.13%)
September 1, 2025

Summary

  • As of today, IONS TTM cash from operations is -$247.01 million, with the most recent change of -$16.45 million (-7.13%) on September 1, 2025.
  • Over the past year, IONS TTM cash from operations has increased by +$104.93 million (+29.81%).
  • IONS TTM cash from operations is now -135.42% below its all-time high of $697.43 million, reached on March 31, 2019.

Performance

IONS TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONScash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

IONS Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-62.9%-14.3%+29.8%
3Y3 Years-1726.5%-438.0%-290.7%
5Y5 Years-244.9%-1179.2%-214.4%

IONS Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-1726.5%at low-186.8%+34.4%-290.7%+54.3%
5Y5-Year-244.9%at low-164.5%+34.4%-214.4%+54.3%
All-TimeAll-Time-183.1%at low-126.3%+34.4%-135.4%+54.3%

IONS Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
-$131.44M(-186.8%)
-$247.01M(-7.1%)
Jun 2025
-
$151.34M(+200.4%)
-$230.57M(+54.1%)
Mar 2025
-
-$150.78M(-29.8%)
-$501.78M(-0.2%)
Dec 2024
-$500.95M(-62.9%)
-$116.14M(-1.0%)
-$500.95M(-42.3%)
Sep 2024
-
-$114.99M(+4.1%)
-$351.94M(-1.7%)
Jun 2024
-
-$119.88M(+20.0%)
-$345.98M(-7.0%)
Mar 2024
-
-$149.94M(-556.2%)
-$323.46M(-5.2%)
Dec 2023
-$307.51M(-12.1%)
$32.87M(+130.1%)
-$307.51M(+43.1%)
Sep 2023
-
-$109.02M(-12.0%)
-$540.57M(-18.6%)
Jun 2023
-
-$97.36M(+27.3%)
-$455.98M(-21.0%)
Mar 2023
-
-$133.99M(+33.1%)
-$376.71M(-37.3%)
Dec 2022
-$274.37M(-990.8%)
-$200.19M(-719.5%)
-$274.37M(-311.8%)
Sep 2022
-
-$24.43M(-35.0%)
$129.51M(+31.7%)
Jun 2022
-
-$18.10M(+42.8%)
$98.37M(+82.8%)
Mar 2022
-
-$31.65M(-115.5%)
$53.81M(+74.7%)
Dec 2021
$30.80M(-14.2%)
$203.69M(+466.5%)
$30.80M(+141.1%)
Sep 2021
-
-$55.57M(+11.3%)
-$74.91M(-153.0%)
Jun 2021
-
-$62.65M(-14.6%)
-$29.61M(-164.9%)
Mar 2021
-
-$54.66M(-155.8%)
-$11.18M(-131.1%)
Dec 2020
$35.89M(-89.6%)
$97.98M(+1053.5%)
$35.89M(-83.4%)
Sep 2020
-
-$10.28M(+76.8%)
$215.85M(+1.2%)
Jun 2020
-
-$44.22M(-482.4%)
$213.32M(-7.4%)
Mar 2020
-
-$7.59M(-102.7%)
$230.42M(-33.3%)
Dec 2019
$345.72M(-42.7%)
$277.93M(+2270.3%)
$345.72M(+88.6%)
Sep 2019
-
-$12.81M(+52.8%)
$183.28M(+7.8%)
Jun 2019
-
-$27.11M(-125.2%)
$170.08M(-75.6%)
Mar 2019
-
$107.70M(-6.7%)
$697.43M(+15.7%)
Dec 2018
$602.89M(+246.2%)
$115.49M(+544.1%)
$602.89M(+18.7%)
Sep 2018
-
-$26.00M(-105.2%)
$507.80M(-9.7%)
Jun 2018
-
$500.24M(+3699.7%)
$562.52M(+770.1%)
Mar 2018
-
$13.16M(-35.5%)
$64.65M(-62.9%)
Dec 2017
$174.15M(+255.3%)
$20.40M(-29.0%)
$174.15M(+36.3%)
Sep 2017
-
$28.72M(+1115.4%)
$127.79M(+4.3%)
Jun 2017
-
$2.36M(-98.1%)
$122.47M(+41.9%)
Mar 2017
-
$122.67M(+572.5%)
$86.33M(+177.0%)
Dec 2016
-$112.11M(-630.7%)
-$25.96M(-210.9%)
-$112.11M(+9.3%)
Sep 2016
-
$23.41M(+169.3%)
-$123.62M(-11.6%)
Jun 2016
-
-$33.78M(+55.4%)
-$110.81M(-837.7%)
Mar 2016
-
-$75.77M(-102.2%)
-$11.82M(-155.9%)
Dec 2015
$21.13M(+236.1%)
-$37.47M(-203.5%)
$21.13M(-83.7%)
Sep 2015
-
$36.22M(-44.5%)
$129.28M(+36.1%)
Jun 2015
-
$65.21M(+252.3%)
$95.01M(+2355.1%)
Mar 2015
-
-$42.83M(-160.6%)
-$4.21M(-167.0%)
Dec 2014
$6.29M(-90.1%)
$70.68M(+3536.0%)
$6.29M(+108.0%)
Sep 2014
-
$1.94M(+105.7%)
-$78.89M(-425.4%)
Jun 2014
-
-$34.02M(-5.2%)
-$15.01M(-136.0%)
Mar 2014
-
-$32.33M(-123.1%)
$41.74M(-34.3%)
Dec 2013
$63.49M(+3284.5%)
-$14.49M(-122.0%)
$63.49M(-44.3%)
Sep 2013
-
$65.82M(+189.5%)
$114.02M(+388.8%)
Jun 2013
-
$22.74M(+315.0%)
$23.33M(+1272.9%)
Mar 2013
-
-$10.58M(-129.3%)
-$1.99M(-206.0%)
Dec 2012
$1.88M(+101.6%)
$36.03M(+244.9%)
$1.88M(+103.2%)
Sep 2012
-
-$24.87M(-865.1%)
-$58.49M(-0.7%)
Jun 2012
-
-$2.58M(+61.6%)
-$58.07M(+28.9%)
Mar 2012
-
-$6.71M(+72.4%)
-$81.67M(+28.9%)
Dec 2011
-$114.80M(-80.5%)
-$24.33M(+0.5%)
-$114.80M(+1.0%)
Sep 2011
-
-$24.45M(+6.6%)
-$115.97M(-2.7%)
Jun 2011
-
-$26.18M(+34.3%)
-$112.95M(-38.2%)
Mar 2011
-
-$39.84M(-56.2%)
-$81.74M(-28.5%)
Dec 2010
-$63.59M(+41.4%)
-$25.50M(-19.0%)
-$63.59M(+8.7%)
Sep 2010
-
-$21.43M(-526.0%)
-$69.62M(+13.4%)
Jun 2010
-
$5.03M(+123.2%)
-$80.39M(+16.1%)
Mar 2010
-
-$21.69M(+31.2%)
-$95.79M(+11.7%)
Dec 2009
-$108.44M(-151.1%)
-$31.53M(+2.1%)
-$108.44M(-12.9%)
Sep 2009
-
-$32.19M(-210.4%)
-$96.08M(-12.5%)
Jun 2009
-
-$10.37M(+69.8%)
-$85.44M(-183.3%)
Mar 2009
-
-$34.35M(-79.1%)
$102.57M(-51.6%)
Dec 2008
$212.03M
-$19.18M(+11.0%)
$212.03M(-23.5%)
Sep 2008
-
-$21.55M(-112.1%)
$277.06M(-10.9%)
DateAnnualQuarterlyTTM
Jun 2008
-
$177.64M(+136.5%)
$311.02M(+135.6%)
Mar 2008
-
$75.11M(+63.8%)
$132.00M(+265.7%)
Dec 2007
$36.09M(+167.8%)
$45.86M(+269.7%)
$36.09M(+293.7%)
Sep 2007
-
$12.40M(+1004.7%)
-$18.63M(+58.6%)
Jun 2007
-
-$1.37M(+93.4%)
-$44.99M(+22.4%)
Mar 2007
-
-$20.80M(-134.4%)
-$57.96M(-8.9%)
Dec 2006
-$53.23M(+13.8%)
-$8.87M(+36.4%)
-$53.23M(+9.4%)
Sep 2006
-
-$13.96M(+2.6%)
-$58.72M(-15.7%)
Jun 2006
-
-$14.33M(+10.8%)
-$50.74M(+9.0%)
Mar 2006
-
-$16.06M(-11.8%)
-$55.77M(+9.7%)
Dec 2005
-$61.74M(+39.3%)
-$14.37M(-140.2%)
-$61.74M(+14.4%)
Sep 2005
-
-$5.98M(+69.1%)
-$72.15M(+18.3%)
Jun 2005
-
-$19.36M(+12.1%)
-$88.26M(+12.0%)
Mar 2005
-
-$22.03M(+11.1%)
-$100.32M(+1.4%)
Dec 2004
-$101.75M(-6.6%)
-$24.78M(-12.2%)
-$101.75M(+7.0%)
Sep 2004
-
-$22.09M(+29.7%)
-$109.38M(+0.6%)
Jun 2004
-
-$31.42M(-33.9%)
-$110.05M(-9.0%)
Mar 2004
-
-$23.47M(+27.6%)
-$100.94M(-5.7%)
Dec 2003
-$95.47M(-1.2%)
-$32.41M(-42.4%)
-$95.47M(-30.6%)
Sep 2003
-
-$22.76M(-2.0%)
-$73.08M(-14.3%)
Jun 2003
-
-$22.30M(-23.9%)
-$63.91M(+33.9%)
Mar 2003
-
-$18.00M(-79.7%)
-$96.66M(-2.4%)
Dec 2002
-$94.38M(-1432.7%)
-$10.02M(+26.3%)
-$94.38M(+1.0%)
Sep 2002
-
-$13.59M(+75.3%)
-$95.30M(-80.8%)
Jun 2002
-
-$55.05M(-249.9%)
-$52.71M(-992.3%)
Mar 2002
-
-$15.73M(-43.9%)
-$4.83M(+21.6%)
Dec 2001
-$6.16M(+73.4%)
-$10.93M(-137.7%)
-$6.16M(-438.3%)
Sep 2001
-
$29.00M(+505.0%)
-$1.14M(+95.9%)
Jun 2001
-
-$7.16M(+58.0%)
-$28.02M(+4.0%)
Mar 2001
-
-$17.06M(-188.3%)
-$29.20M(-25.9%)
Dec 2000
-$23.19M(+52.1%)
-$5.92M(-379.5%)
-$23.19M(+17.8%)
Sep 2000
-
$2.12M(+125.4%)
-$28.21M(+28.4%)
Jun 2000
-
-$8.33M(+24.6%)
-$39.40M(+13.2%)
Mar 2000
-
-$11.05M(-1.0%)
-$45.38M(+6.2%)
Dec 1999
-$48.36M(-39.3%)
-$10.94M(-20.6%)
-$48.36M(-1.8%)
Sep 1999
-
-$9.07M(+36.6%)
-$47.49M(+1.0%)
Jun 1999
-
-$14.31M(-1.9%)
-$47.96M(-51.9%)
Mar 1999
-
-$14.04M(-39.4%)
-$31.58M(+9.0%)
Dec 1998
-$34.72M(-68.9%)
-$10.07M(-5.6%)
-$34.72M(-12.5%)
Sep 1998
-
-$9.54M(-560.7%)
-$30.85M(-28.5%)
Jun 1998
-
$2.07M(+112.0%)
-$24.01M(+29.5%)
Mar 1998
-
-$17.18M(-177.1%)
-$34.08M(-65.4%)
Dec 1997
-$20.55M(+2.8%)
-$6.20M(-129.6%)
-$20.60M(-0.5%)
Sep 1997
-
-$2.70M(+66.3%)
-$20.50M(+13.5%)
Jun 1997
-
-$8.00M(-116.2%)
-$23.70M(-0.9%)
Mar 1997
-
-$3.70M(+39.3%)
-$23.50M(-10.8%)
Dec 1996
-$21.15M(-40.3%)
-$6.10M(-3.4%)
-$21.20M(+3.6%)
Sep 1996
-
-$5.90M(+24.4%)
-$22.00M(-43.8%)
Jun 1996
-
-$7.80M(-457.1%)
-$15.30M(-39.1%)
Mar 1996
-
-$1.40M(+79.7%)
-$11.00M(+27.2%)
Dec 1995
-$15.08M(+1.0%)
-$6.90M(-962.5%)
-$15.10M(-34.8%)
Sep 1995
-
$800.00K(+122.9%)
-$11.20M(+20.0%)
Jun 1995
-
-$3.50M(+36.4%)
-$14.00M(-0.7%)
Mar 1995
-
-$5.50M(-83.3%)
-$13.90M(+8.6%)
Dec 1994
-$15.23M(+0.5%)
-$3.00M(-50.0%)
-$15.20M(-7.0%)
Sep 1994
-
-$2.00M(+41.2%)
-$14.20M(+2.1%)
Jun 1994
-
-$3.40M(+50.0%)
-$14.50M(+15.7%)
Mar 1994
-
-$6.80M(-240.0%)
-$17.20M(-12.4%)
Dec 1993
-$15.30M(+21.0%)
-$2.00M(+13.0%)
-$15.30M(+13.6%)
Sep 1993
-
-$2.30M(+62.3%)
-$17.70M(+7.3%)
Jun 1993
-
-$6.10M(-24.5%)
-$19.10M(-9.8%)
Mar 1993
-
-$4.90M(-11.4%)
-$17.40M(+10.3%)
Dec 1992
-$19.37M(-1201.1%)
-$4.40M(-18.9%)
-$19.40M(-23.6%)
Sep 1992
-
-$3.70M(+15.9%)
-$15.70M(-4.7%)
Jun 1992
-
-$4.40M(+36.2%)
-$15.00M(-38.9%)
Mar 1992
-
-$6.90M(-885.7%)
-$10.80M(-620.0%)
Dec 1991
-$1.49M
-$700.00K(+76.7%)
-$1.50M(-87.5%)
Sep 1991
-
-$3.00M(-1400.0%)
-$800.00K(-136.4%)
Jun 1991
-
-$200.00K(-108.3%)
$2.20M(-8.3%)
Mar 1991
-
$2.40M
$2.40M

FAQ

  • What is Ionis Pharmaceuticals, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Ionis Pharmaceuticals, Inc.?
  • What is Ionis Pharmaceuticals, Inc. annual cash from operations year-on-year change?
  • What is Ionis Pharmaceuticals, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Ionis Pharmaceuticals, Inc.?
  • What is Ionis Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
  • What is Ionis Pharmaceuticals, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Ionis Pharmaceuticals, Inc.?
  • What is Ionis Pharmaceuticals, Inc. TTM cash from operations year-on-year change?

What is Ionis Pharmaceuticals, Inc. annual cash from operations?

The current annual cash from operations of IONS is -$500.95M

What is the all-time high annual cash from operations for Ionis Pharmaceuticals, Inc.?

Ionis Pharmaceuticals, Inc. all-time high annual cash from operations is $602.89M

What is Ionis Pharmaceuticals, Inc. annual cash from operations year-on-year change?

Over the past year, IONS annual cash from operations has changed by -$193.43M (-62.90%)

What is Ionis Pharmaceuticals, Inc. quarterly cash from operations?

The current quarterly cash from operations of IONS is -$131.44M

What is the all-time high quarterly cash from operations for Ionis Pharmaceuticals, Inc.?

Ionis Pharmaceuticals, Inc. all-time high quarterly cash from operations is $500.24M

What is Ionis Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?

Over the past year, IONS quarterly cash from operations has changed by -$16.45M (-14.30%)

What is Ionis Pharmaceuticals, Inc. TTM cash from operations?

The current TTM cash from operations of IONS is -$247.01M

What is the all-time high TTM cash from operations for Ionis Pharmaceuticals, Inc.?

Ionis Pharmaceuticals, Inc. all-time high TTM cash from operations is $697.43M

What is Ionis Pharmaceuticals, Inc. TTM cash from operations year-on-year change?

Over the past year, IONS TTM cash from operations has changed by +$104.93M (+29.81%)
On this page